Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare BATS:ALFANYSEARCA:FBT On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeALFAAlphaClone Alternative Alpha ETF$62.10$62.10$0.00▼$0.00N/AN/AN/AN/AFBTFirst Trust NYSE Arca Biotechnology Index Fund$162.06-1.3%$161.07$141.38▼$183.60$1.00B0.7924,034 shs19,852 shs10 Stocks Set to Soar in Summer 2025Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceALFAAlphaClone Alternative Alpha ETF0.00%0.00%0.00%0.00%0.00%FBTFirst Trust NYSE Arca Biotechnology Index Fund0.00%+1.81%-0.28%+8.00%+7.28%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationALFAAlphaClone Alternative Alpha ETFN/AN/AN/AN/AN/AN/AN/AN/AFBTFirst Trust NYSE Arca Biotechnology Index FundN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceALFAAlphaClone Alternative Alpha ETF 0.00N/AN/AN/AFBTFirst Trust NYSE Arca Biotechnology Index Fund 2.66Moderate Buy$162.06N/ACurrent Analyst Ratings BreakdownCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookALFAAlphaClone Alternative Alpha ETFN/AN/AN/AN/AN/AN/AFBTFirst Trust NYSE Arca Biotechnology Index FundN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateALFAAlphaClone Alternative Alpha ETFN/AN/A0.00∞N/AN/AN/AN/AN/AFBTFirst Trust NYSE Arca Biotechnology Index FundN/AN/A21.72∞N/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthALFAAlphaClone Alternative Alpha ETFN/AN/AN/AN/AN/AFBTFirst Trust NYSE Arca Biotechnology Index Fund$1.170.72%N/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipALFAAlphaClone Alternative Alpha ETFN/AFBTFirst Trust NYSE Arca Biotechnology Index FundN/AInsider OwnershipCompanyInsider OwnershipALFAAlphaClone Alternative Alpha ETFN/AFBTFirst Trust NYSE Arca Biotechnology Index FundN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableALFAAlphaClone Alternative Alpha ETFN/AN/AN/ANot OptionableFBTFirst Trust NYSE Arca Biotechnology Index FundN/A6.20 millionN/ANot OptionableDOTD, LTG, ALFA, and FBT HeadlinesRecent News About These CompaniesIs First Trust NYSE Arca Biotechnology ETF (FBT) a Strong ETF Right Now?June 24, 2025 | zacks.comShould You Invest in the First Trust NYSE Arca Biotechnology ETF (FBT)?June 17, 2025 | zacks.comFBT: This 30-Stock Biotech ETF Isn't Worth The Risk TodayMay 18, 2025 | seekingalpha.comIs First Trust NYSE Arca Biotechnology ETF (FBT) a Strong ETF Right Now?April 24, 2025 | zacks.comFirst Trust NYSE Arca Biotechnology UCITS ETF Class A USD AccumulationApril 17, 2025 | uk.investing.comShould You Invest in the First Trust NYSE Arca Biotechnology ETF (FBT)?April 16, 2025 | zacks.comIs First Trust NYSE Arca Biotechnology ETF (FBT) a Strong ETF Right Now?February 21, 2025 | zacks.comShould You Invest in the First Trust NYSE Arca Biotechnology ETF (FBT)?February 10, 2025 | zacks.com(FBT) Trading ReportJanuary 25, 2025 | news.stocktradersdaily.comN(FBT) Pivots Trading Plans and Risk ControlsJanuary 15, 2025 | news.stocktradersdaily.comNIs First Trust NYSE Arca Biotechnology ETF (FBT) a Strong ETF Right Now?December 20, 2024 | zacks.comShould You Invest in the First Trust NYSE Arca Biotechnology ETF (FBT)?December 10, 2024 | zacks.comIs First Trust NYSE Arca Biotechnology ETF (FBT) a Strong ETF Right Now?October 18, 2024 | zacks.comShould You Invest in the First Trust NYSE Arca Biotechnology ETF (FBT)?October 7, 2024 | zacks.comWhen (FBT) Moves Investors should ListenSeptember 19, 2024 | news.stocktradersdaily.comNIs First Trust NYSE Arca Biotechnology ETF (FBT) a Strong ETF Right Now?August 14, 2024 | zacks.comShould You Invest in the First Trust NYSE Arca Biotechnology ETF (FBT)?August 6, 2024 | zacks.comLearn to Evaluate (FBT) using the ChartsJuly 31, 2024 | news.stocktradersdaily.comNNewsBriefs - NYSE Arca confirms approval to list spot Ethereum ETFs from Grayscale and BitwiseJuly 22, 2024 | cryptobriefing.comCIs First Trust NYSE Arca Biotechnology ETF (FBT) a Strong ETF Right Now?June 11, 2024 | zacks.comMedia Sentiment Over TimeDOTD, LTG, ALFA, and FBT Company DescriptionsAlphaClone Alternative Alpha ETF BATS:ALFA$62.10 0.00 (0.00%) As of 09/1/2022First Trust NYSE Arca Biotechnology Index Fund NYSEARCA:FBT$162.06 -2.16 (-1.32%) As of 04:10 PM EasternThe First Trust NYSE Arca Biotechnology Index Fund (FBT) is an exchange-traded fund that is based on the NYSE Arca Biotechnology index. The fund tracks an equal-weighted index of US biotechnology stocks. FBT was launched on Jun 19, 2006 and is managed by First Trust. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas CoreWeave's $9 Billion Power Play for Core Scientific Micron Insiders Sell But Investors Should Buy, Buy, Buy Could Dutch Bros Dethrone Starbucks? Why Investors Are Perking Up ExxonMobil: Limited Risk and Lots of Reward With This Oil Play D-Wave Is Rising Again Despite Dilution—What’s the Deal? Datadog Joins S&P 500, Triggering a New Wave of Upside MarketBeat Week in Review – 06/30 - 07/04 The Apple Comeback Will Be Better Than the Setback Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
